U.S. COMPANY FILING
VERTEX PHARMACEUTICALS INC / MA — Form 8-K filed 2026-02-12
Filing text preview
Vertex Pharmaceuticals filed an 8-K on February 12, 2026, reporting its consolidated financial results for Q4 and full year 2025. The press release is attached as Exhibit 99.1. No specific financial figures were provided in the filing.
This preview uses text already stored in ReportGem and does not fetch the document from object storage during SEO generation. Review the internal filing record and the official SEC source before relying on it.
Open filing record